Tomohisa Okada

Tomohisa Okada

Auto-generated profile, based on publicly available information

Tomohisa Okada

Human Brain Research Center, Graduate School of Medicine Kyoto University Kyoto Japan

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2025 in Nature
Verified
Journal Article
Open access
PDF file
NSNobukatsu Sawamoto
Nobukatsu Sawamoto
DDDaisuke Doi
Daisuke Doi
ENEtsuro Nakanishi
Etsuro Nakanishi
MSMasanori Sawamura
Masanori Sawamura
TKTakayuki Kikuchi
Takayuki Kikuchi
JTJun Takahashi
Jun Takahashi
Parkinson’s disease is caused by the loss of dopamine neurons, causing motor symptoms. Initial cell therapies using fetal tissues showed promise but had complications and ethical concerns1,2,3,4,5. Pluripotent stem (PS) cells emerged as a promising alternative for developing safe and effective treatments6. In this phase I/II trial at Kyoto University Hospital, seven patients (ages 50–69) received bilateral transplantation of dopaminergic progenitors derived from induced PS (iPS) cells. Primary outcomes focused on safety and adverse events, while secondary outcomes assessed motor symptom changes and dopamine production for 24 months. There were no serious adverse events, with 73 mild to moderate events. Patients’ anti-parkinsonian medication doses were maintained unless therapeutic adjustments were required, resulting in increased dyskinesia. Magnetic resonance imaging showed no graft overgrowth. Among six patients subjected to efficacy evaluation, four showed improvements in the Movement Disorder Society Unified Parkinson’s Disease Rating Scale part III OFF score, and five showed improvements in the ON scores. The average changes of all six patients were 9.5 (20.4%) and 4.3 points (35.7%) for the OFF and ON scores, respectively. Hoehn–Yahr stages improved in four patients. Fluorine-18-l-dihydroxyphenylalanine (18F-DOPA) influx rate constant (Ki) values in the putamen increased by 44.7%, with higher increases in the high-dose group. Other measures showed minimal changes. This trial (jRCT2090220384) demonstrated that allogeneic iPS-cell-derived dopaminergic progenitors survived, produced dopamine and did not form tumours, therefore suggesting safety and potential clinical benefits for Parkinson’s disease.

6 January 2015 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
ASAkihiko Sakata
Akihiko Sakata
TOTomohisa Okada
Tomohisa Okada
AYAkira Yamamoto
Akira Yamamoto
MKMitsunori Kanagaki
Mitsunori Kanagaki
YFYasutaka Fushimi
Yasutaka Fushimi
KTKaori Togashi
Kaori Togashi

22 August 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HFHikaru Fukutomi
Hikaru Fukutomi
MGMatthew F. Glasser
Matthew F. Glasser
KMKatsutoshi Murata
Katsutoshi Murata
TAThai Akasaka
Thai Akasaka
KFKoji Fujimoto
Koji Fujimoto
THTakuya Hayashi
Takuya Hayashi
Diffusion tensor imaging (DTI) and neurite orientation dispersion and density imaging (NODDI) are widely used models to infer microstructural features in the brain from diffusion-weighted MRI. Several studies have recently applied both models to increase sensitivity to biological changes, however, it remains uncertain how these measures are associated. Here we show that cortical distributions of DTI and NODDI are associated depending on the choice of b-value, a factor reflecting strength of diffusion weighting gradient. We analyzed a combination of high, intermediate and low b-value data of multi-shell diffusion-weighted MRI (dMRI) in healthy 456 subjects of the Human Connectome Project using NODDI, DTI and a mathematical conversion from DTI to NODDI. Cortical distributions of DTI and DTI-derived NODDI metrics were remarkably associated with those in NODDI, particularly when applied highly diffusion-weighted data (b-value = 3000 sec/mm2). This was supported by simulation analysis, which revealed that DTI-derived parameters with lower b-value datasets suffered from errors due to heterogeneity of cerebrospinal fluid fraction and partial volume. These findings suggest that high b-value DTI redundantly parallels with NODDI-based cortical neurite measures, but the conventional low b-value DTI is hard to reasonably characterize cortical microarchitecture.

1 June 2022 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Open access
PDF file
TOTomohisa Okada
Tomohisa Okada
KFKoji Fujimoto
Koji Fujimoto
YFYasutaka Fushimi
Yasutaka Fushimi
TAThai Akasaka
Thai Akasaka
DTDinh H. D. Thuy
Dinh H. D. Thuy
TITadashi Isa
Tadashi Isa
Neuroimaging at 7 Tesla: a pictorial narrative review Tomohisa Okada, Koji Fujimoto, Yasutaka Fushimi, Thai Akasaka, Dinh H. D. Thuy, Atsushi Shima, Nobukatsu Sawamoto, Naoya Oishi, Zhilin Zhang, Takeshi Funaki, Yuji Nakamoto, Toshiya Murai, Susumu Miyamoto, Ryosuke Takahashi, Tadashi Isa

1 June 2015 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
GOGosuke Okubo
Gosuke Okubo
TOTomohisa Okada
Tomohisa Okada
AYAkira Yamamoto
Akira Yamamoto
MKMitsunori Kanagaki
Mitsunori Kanagaki
YFYasutaka Fushimi
Yasutaka Fushimi
KTKaori Togashi
Kaori Togashi

19 January 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TYTakayuki Yamamoto
Takayuki Yamamoto
TOTomohisa Okada
Tomohisa Okada
YFYasutaka Fushimi
Yasutaka Fushimi
AYAkira Yamamoto
Akira Yamamoto
KFKoji Fujimoto
Koji Fujimoto
KTKaori Togashi
Kaori Togashi
Compressed sensing (CS) reconstructions of under-sampled measurements generate missing data based on assumptions of image sparsity. Non-contrast time-of-flight MR angiography (TOF-MRA) is a good candidate for CS based acceleration, as MRA images feature bright trees of sparse vessels over a well-suppressed anatomical background signal. A short scan time derived from CS is beneficial for patients of moyamoya disease (MMD) because of the frequency of MR scans. The purpose of this study was to investigate the reliability of TOF-MRA with CS in the evaluation of MMD. Twenty-two patients were examined using TOF-MRA with CS (CS-TOF) and parallel imaging (PI-TOF). The acceleration factors were 3 (CS3) and 5 (CS5) for CS-TOF, and 3 (PI3) for PI-TOF. Two neuroradiologists evaluated the MMD grading according to stenosis/occlusion scores using the modified Houkin’s system, and the visibility of moyamoya vessels (MMVs) using a 3-point scale. Concordance was calculated with Cohen’s κ. The numbers of MMVs in the basal ganglia were compared using Bland-Altman analysis and Wilcoxon’s signed-rank tests. MRA scan times were 4:07, 3:53, and 2:42 for PI3, CS3, and CS5, respectively. CS-reconstruction completed within 10 minutes. MMD grading and MMV visibility scales showed excellent correlation (κ > .966). Although the number of MMVs was significantly higher in CS3 than in PI3 (p < .0001) and CS5 (p < .0001), Bland-Altman analysis showed a good agreement between PI3, CS3, and CS5. Compressed sensing can accelerate TOF-MRA with improved visualization of small collaterals in equivalent time (CS3) or equivalent results in a shorter scan time (CS5).